Matthew Sherwood, MD, MHS(@mw_sherwood) 's Twitter Profileg
Matthew Sherwood, MD, MHS

@mw_sherwood

Codirector of the Structural Heart Program, Cath Lab and LAAC program at Inova Heart and Vascular Institute, husband of a neonatologist, and proud father of 2

ID:2391447849

calendar_today07-03-2014 16:37:30

726 Tweets

786 Followers

226 Following

Follow People
Inova Schar Heart and Vascular(@ISHVnews) 's Twitter Profile Photo

Excited that Palak Shah, Jason F. Goldberg MD MS were awarded nearly $1.4 million American Heart Association/Enduring Hearts grant to develop test to optimize immunosuppression meds -- improve outcomes in pediatric heart transplant. Inova Schar Heart and Vascular leads multicenter consortium
bit.ly/3JtR2as

Excited that @PalakShahMD, @JasonGoldbergMD were awarded nearly $1.4 million @American_Heart/@EnduringHearts grant to develop test to optimize immunosuppression meds -- improve outcomes in pediatric heart transplant. @ISHVnews leads multicenter consortium bit.ly/3JtR2as
account_circle
Massimo(@Rainmaker1973) 's Twitter Profile Photo

Arshia Goswami, India's 'youngest deadlifter' who can lift 75 kg (165 lbs) and is just 9 years old.

[📹 fit_arshia]

account_circle
Inova Schar Heart and Vascular(@ISHVnews) 's Twitter Profile Photo

Drug-coated balloons shown to be potentially beneficial for management of coronary in-stent restenosis in report of AGENT IDE. Proud of contributions of @ISVHnews Structural Heart team in this study Wayne Batchelor, MD Behnam N. Tehrani, MD

jamanetwork.com/journals/jama/…

Drug-coated balloons shown to be potentially beneficial for management of coronary in-stent restenosis in report of AGENT IDE. Proud of contributions of @ISVHnews Structural Heart team in this study @_WayneBatchelor @behnam_tehrani jamanetwork.com/journals/jama/…
account_circle
Abdulla A. Damluji, MD, PhD(@DrDamluji) 's Twitter Profile Photo

TAVR in low-risk patients: importance of lifetime management: Frontiers

🥸We are doing more and more TAVRs in young low-risk patients: Matthew Sherwood, MD, MHS

😱Mohamad Bahij Moumneh summarizes the challenges and opportunities for TAVR in low-risk patients - bravo!

🥸Summary is below

👇👇

TAVR in low-risk patients: importance of lifetime management: @FrontiersIn 🥸We are doing more and more TAVRs in young low-risk patients: @mw_sherwood 😱@BahijMoumneh summarizes the challenges and opportunities for TAVR in low-risk patients - bravo! 🥸Summary is below 👇👇
account_circle
Inova Schar Heart and Vascular(@ISHVnews) 's Twitter Profile Photo

Special Episode Minority Leaders Podcast
Algene Sajery, Kelly Epps, MD, Suzanne Walker
raise awareness of heart disease, the silent killer that disproportionately affects Black women
bit.ly/3wajSZS

Feb 2 16th Annual DMV Links Red Dress Event bit.ly/3Sq05x1

Special Episode Minority Leaders Podcast @AlgeneSajery, @drkellyepps, Suzanne Walker raise awareness of heart disease, the silent killer that disproportionately affects Black women bit.ly/3wajSZS Feb 2 16th Annual DMV Links Red Dress Event bit.ly/3Sq05x1
account_circle
Inova Schar Heart and Vascular(@ISHVnews) 's Twitter Profile Photo

Thrilled to share that Shashank Sinha, MD, MSc, FACC, FAHA is 1 of 60 chosen for 2024 Class of Presidential Leadership Scholars, a highly selective program focusing on leadership principles of past US presidents

presidentialleadershipscholars.org/2024-class-of-…

Thrilled to share that @ShashankSinhaMD is 1 of 60 chosen for 2024 Class of Presidential Leadership Scholars, a highly selective program focusing on leadership principles of past US presidents presidentialleadershipscholars.org/2024-class-of-…
account_circle
Inova Schar Heart and Vascular(@ISHVnews) 's Twitter Profile Photo

Learn more about improving CV health in patients with cancer
Join Inova Schar Heart and Vascular D’Aniello Chair, CardioOncology, Ana Barac, MD, PhD, FACC, FAHA & Bonnie Ky for this interdisciplinary @ACCIntouch HH Course Feb 9-11 @inovaschar

bit.ly/3U92NJP

Learn more about improving CV health in patients with cancer Join @ISHVnews D’Aniello Chair, CardioOncology, @AnaBaracCardio & Bonnie Ky for this interdisciplinary @ACCIntouch HH Course Feb 9-11 @inovaschar bit.ly/3U92NJP
account_circle
Inova Schar Heart and Vascular(@ISHVnews) 's Twitter Profile Photo

In , Matthew Sherwood, MD, MHS Amit N. Vora, MD MPH provide perspective & context for results of analysis by Ueyama et al of data on reoperation vs TMVR in patients with failed mitral prostheses

jacc.org/doi/10.1016/j.…
jacc.org/doi/10.1016/j.…

In #JACC, @mw_sherwood @anvoramd provide perspective & context for results of analysis by Ueyama et al of data on reoperation vs TMVR in patients with failed mitral prostheses jacc.org/doi/10.1016/j.… jacc.org/doi/10.1016/j.…
account_circle
Matthew Sherwood, MD, MHS(@mw_sherwood) 's Twitter Profile Photo

So proud of our growing Inova Schar Heart and Vascular Inova Structural heart program. 104 TEERs in 2023 (also 450 TAVRs + 176 LAAOs). Our first TEER of 2024 was a doozy. Commissural flail segment A1-P1. Used XTx2. Severe MR down to trace. Amazing imaging Abbas (Reza) Emaminia Wayne Batchelor, MD Abdulla A. Damluji, MD, PhD

account_circle
Inova Schar Heart and Vascular(@ISHVnews) 's Twitter Profile Photo

In JACC Journals, Behnam N. Tehrani, MD Wayne Batchelor, MD, David Spinosa discuss Kobayashi et al analysis of PERT Registry data and development of strategies to treat high risk patients with PE.

doi.org/10.1016/j.jacc…
doi.org/10.1016/j.jacc…

In @JACCJournals, @behnam_tehrani @_WayneBatchelor, David Spinosa discuss Kobayashi et al analysis of PERT Registry data and development of strategies to treat high risk patients with PE. doi.org/10.1016/j.jacc… doi.org/10.1016/j.jacc…
account_circle
Inova Schar Heart and Vascular(@ISHVnews) 's Twitter Profile Photo

TRILUMINATE Pivotal showed T-TEER reduced TR. Is there efficacy beyond KCCQ score?
Wayne Batchelor, MD Abbas (Reza) Emaminia Matthew Sherwood, MD, MHS comment on Arnold, et al analysis of health status outcomes
JACC Journals
doi.org/10.1016/j.jacc…
doi.org/10.1016/j.jacc…

TRILUMINATE Pivotal showed T-TEER reduced TR. Is there efficacy beyond KCCQ score? @_WayneBatchelor @RezaEmaminia @mw_sherwood comment on Arnold, et al analysis of health status outcomes @JACCJournals doi.org/10.1016/j.jacc… doi.org/10.1016/j.jacc…
account_circle